Agile Therapeutics Investor Relations Material
Latest events
Q4 2023
Agile Therapeutics
M&A Announcement
25 Aug, 2024
Q2 2024
12 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Agile Therapeutics Inc
Access all reports
Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. The company offers Sklya, a transdermal contraceptive patch that provides twice weekly dosing of a combination of estradiol and norgestimate hormones for the prevention of pregnancy, as well as for moderate acne treatment in women. Agile Therapeutics, Inc. was incorporated in 1997 and is headquartered in Princeton, New Jersey.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
AGRX
Country
🇺🇸 United States